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Despite numerous reviews [Brüning and Bolt
2000; International Agency for Research on
Cancer (IARC) 1995; Institute of Medicine
2002; Lynge et al. 1997; McLaughlin and
Blot 1997; National Toxicology Program
(NTP) 2002; Wartenberg et al. 2000; Weiss
1996; Wong 2004], including those of two
multidisciplinary expert panels that con-
cluded that trichloroethylene (TCE) is “prob-
ably” (IARC 1995) or “reasonably anticipated
to be” (NTP 2002) carcinogenic in humans,
the interpretation of the epidemiologic stud-
ies on cancer and TCE exposure remains an
area of considerable debate. The strongest
epidemiologic evidence for associations
between TCE exposure and cancer is for liver
cancer, kidney cancer, and lymphomas, but
perspectives have differed about the causal
inferences regarding the human carcinogenic-
ity of TCE that can be drawn from the epi-
demiologic database as a whole (e.g., Mandel
and Kelsh 2001; Wartenberg et al. 2000).
Some of the key issues underlying different
interpretations are the use of different qualita-
tive and quantitative (e.g., meta-analysis)
methods to synthesize the body of evidence
and the weight given to studies on the basis of
different measures of cancer risk (e.g., inci-
dence versus mortality) and different methods
of exposure assessment. In addition, interpre-
tation of data on lymphomas poses unique
challenges because of the use of different clas-
sification systems and an evolving under-
standing of their etiology. As discussed in the
overview article on this mini-monograph
(Chiu et al. 2006a), these are all issues on
which the National Academy of Sciences
(NAS) has been asked to provide advice.
In this review we first summarize the
recent epidemiologic literature on TCE expo-
sure and cancer occurrence and then discuss
the issues identiﬁed above as key to interpret-
ing the larger body of epidemiologic evidence.
Although some scientific conclusions can be
drawn from this updated body of data, specu-
lation about the impact of these data on the
ﬁnal TCE risk assessment would be premature
at this point, given the ongoing NAS consul-
tation discussed in the overview article by
Chiu et al. (2006a) and the planned revision
of the U.S. Environmental Protection Agency
(EPA) TCE risk assessment. Therefore, the
purpose here and throughout this mini-mono-
graph is to review recently published scientiﬁc
literature in the context of how it informs the
key scientiﬁc issues believed to be most critical
in developing a revised risk assessment.
Epidemiologic Studies on
Cancer and TCE Exposure
The epidemiologic analysis in the U.S. EPA
draft TCE risk assessment (U.S. EPA 2001)
was supported in large part by the review by
Wartenberg et al. (2000). This review identi-
ﬁed more than 80 studies that evaluated can-
cer and TCE exposure, concluding that the
evidence more firmly supported associations
of TCE exposure with kidney and liver can-
cer while providing some support for associa-
tions with non-Hodgkin lymphoma (NHL).
Wartenberg et al. (2000) also noted possible
associations between TCE exposure and
multiple myeloma and prostate, laryngeal,
and colon cancer as well as cervical cancer
and TCE or perchloroethylene exposure.
A number of studies and literature reviews
have been published since 2000. Tables 1–3
provide short descriptions of these studies,
which include historical or retrospective cohort
studies (Table 1), case–control studies (Table 2),
and ecologic or community studies (Table 3).
Most of the TCE cohort and case–control stud-
ies involve occupational exposure to TCE, pri-
marily by inhalation, whereas community
studies usually involve contaminated groundwa-
ter where potential TCE exposure may be
through both ingestion of drinking water and
inhalation from TCE vapor intrusion into sub-
surface residential areas or from showering.
Many of these studies employed more sophisti-
cated exposure assessment approaches, allowing
better identiﬁcation of likely TCE-exposed sub-
jects (Brüning et al. 2003; Charbotel et al.
2006; DeRoos et al. 2001; Dumas et al. 2000;
Hansen et al. 2001; Pesch et al. 2000a, 2000b;
Raaschou-Nielsen et al. 2003; Zhao et al.
2005). Tables 4–7 show corresponding study
results for cancers that either are newly reported
to have associations (Table 4, total cancers and
cancers of the bladder, breast, and esophagus) or
have drawn the most attention in previous
reviews [Table 5, kidney cancer or renal cell car-
cinoma (RCC); Table 6, cancer of the liver or
liver and biliary passages; Table 7, lymphomas].
These recent studies substantially expand the
epidemiologic database, providing additional
insights on potential causal associations between
TCE exposure and cancer occurrence. The fol-
lowing discussion focuses on the three groups of
end points—kidney cancer and RCC, liver and
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A large body of epidemiologic evidence exists for exploring causal associations between cancer and
trichloroethylene (TCE) exposure. The U.S. Environmental Protection Agency 2001 draft TCE
health risk assessment concluded that epidemiologic studies, on the whole, support associations
between TCE exposure and excess risk of kidney cancer, liver cancer, and lymphomas, and, to a
lesser extent, cervical cancer and prostate cancer. As part of a mini-monograph on key issues in the
health risk assessment of TCE, this article reviews recently published scientiﬁc literature examining
cancer and TCE exposure and identiﬁes four issues that are key to interpreting the larger body of
epidemiologic evidence: a) relative sensitivity of cancer incidence and mortality data; b) different
classiﬁcations of lymphomas, including non-Hodgkin lymphoma; c) differences in data and meth-
ods for assigning TCE exposure status; and d) different methods employed for causal inferences,
including statistical or meta-analysis approaches. The recent epidemiologic studies substantially
expand the epidemiologic database, with seven new studies available on kidney cancer and some-
what fewer studies available that examine possible associations at other sites. Overall, recently pub-
lished studies appear to provide further support for the kidney, liver, and lymphatic systems as
targets of TCE toxicity, suggesting, as do previous studies, modestly elevated (typically 1.5–2.0)
site-speciﬁc relative risks, given exposure conditions in these studies. However, a number of chal-
lenging issues need to be considered before drawing causal conclusions about TCE exposure and
cancer from these data. Key words: cancer, drinking water exposures, epidemiology, occupational
exposures, risk assessment, trichloroethylene. Environ Health Perspect 114:1471–1478 (2006).
doi:10.1289/ehp.8949 available via http://dx.doi.org/ [Online 9 May 2006]biliary cancer, and lymphomas—previously
identiﬁed as having the strongest evidence for
potential causal association with TCE exposure
(IARC 1995; NTP 2002; Wartenberg et al.
2000).
The studies available since 2000 report
consistent associations between kidney cancer
or RCC and TCE exposure (Table 5). Two
cohort studies with large numbers of exposed
cases (Raaschou-Nielsen et al. 2003; Zhao
et al. 2005) observed statistically significant
associations with greater exposure level or
duration of employment. These ﬁndings were
supported by three recent case–control studies
assessing TCE exposure in the metal industry
in Germany (Brüning et al. 2003; Pesch et al.
2000a) and in France (Charbotel et al. 2006).
The studies by Brüning et al. (2003) and
Charbotel et al. (2006) were designed speciﬁ-
cally to examine the a priori hypothesis of an
association between RCC and TCE exposure.
Charbotel et al. (2006) suggested that exposure
intensity may contribute to the risk associated
with cumulative exposure because risks were
higher for subjects in the highest cumulative
exposure category with peak TCE exposure
[odds ratio (OR) = 2.7; 95% conﬁdence inter-
val (CI), 1.1–7.1] than for subjects with only
high cumulative exposure (OR = 2.2; 95% CI,
1.0–4.6), compared with unexposed subjects.
Most of the recent cohort studies also pro-
vide information as to possible association
between TCE and liver and/or biliary tract
cancer, although many examined only the
combined category (Table 6). Grouping the
adjacent, but anatomically distinct, end points
of primary liver cancer and biliary cancer,
which includes cancer of the gallbladder, lim-
its application of mode-of-action data and
may introduce misclassification bias. The
recent Nordic cohort studies (Hansen 2004;
Raaschou-Nielsen et al. 2003) disaggregate
these cancers, and the addition of these two
studies doubles the total number of epidemio-
logic studies providing information for primary
liver cancer. The study by Raaschou-Nielsen
et al. (2003), having greater statistical power
because of its larger cohort size, suggested that
both sites are possible targets of TCE toxicity,
reporting a standardized incidence ratio (SIR)
for primary liver cancer similar to that for gall-
bladder and biliary tract cancer. Risks for the
larger category of liver and biliary tract cancers
are presented in both the Nordic studies and
the two recent community studies (Lee et al.
2003; Morgan and Cassady 2002). These stud-
ies together suggest a modest association (risks
between 1.1 and 2.8), with no clear pattern
with duration of exposure. Furthermore, none
of the studies have sufﬁcient power to identify
sex differences in susceptibility.
New information on lymphomas, includ-
ing NHL and leukemia, and TCE exposure
comes from cohort and community studies
(Table 7). Both Nordic studies (Hansen et al.
2001; Raaschou-Nielsen et al. 2003) reported
statistically significant associations with 
NHL, with increasing SIRs with increasing
duration of employment. The risk of NHL
mortality in Zhao et al. (2005) was more
consistent than the NHL incidence with risks
observed in Nordic cohorts. Except in the 
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Table 1. Occupational cohort studies of cancer and TCE exposure.
Reference Description Size of study and comparison group Exposure assessment
Aircraft and aerospace workers
Zhao et al. 2005 Aerospace workers with at least 2 years of  6,044 (2,689 with high  Industrial hygienist assessment from walk-through visits, 
employment at Boeing/Rockwell/Rocketdyne cumulative exposure to TCE). interviews, and review of historical facility reports. Each job 
(Santa Susana Field Laboratory, Ventura, CA)  Mortality rates of subjects in  title ranked for presumptive TCE exposure as high (3),
between 1950 and 1993. Cancer  lowest TCE exposure category. medium (2), low (1), or no (0) exposure. Cumulative TCE 
mortality as of 31 December 2001. assigned to individual subjects using JEM. Exposure–response
patterns assessed using cumulative exposure.
Aerospace workers with at least 2 years of  5,049 (2,227 with high 
employment at Boeing/Rockwell/Rocketdyne  cumulative exposure to TCE).
(Santa Susana Field Laboratory) between  Incidence rates of subjects in 
1950 and 1993 who were alive as of 1988.  lowest TCE exposure category.
Cancer incidence was ascertained between 
1988 and 2000.
Cohorts identiﬁed from U-TCA
Hansen et al. 2001 Workers biologically monitored for  803 (16,703 P-Y). Cancer  Of the 803 subjects, 712 had U-TCA, 89 had air TCE 
occupational exposure to TCE between 1947  incidence rates of the Danish  measurement records and 2 had records of both types. 
and 1989 using U-TCA and air TCE  population. Median TCE concentration was 19 mg/m3. Mean and median 
measurements between 1947 and 1989 and  concentrations of U-TCA were 250 µmol/L and 92 µmol/L, 
alive as of 1 April 1968. Follow-up for cancer  respectively. There were on average 2.2 U-TCA measurements
incidence from 1 April 1968 or date of ﬁrst  per individual.
employment through 31 December 1996.
Other cohorts
Chang et al. 2005 Workers employed between 1978 and  86,868 (1,380,355, P-Y). National Labor Department inspection reports and the 
31 December 1998 at an electronics factory  Incidence rates of Taiwanese  company’s import/export statistics indicated use of many 
in Taiwan. Follow-up began on 1 January 1979 population. chlorinated solvents, including TCE, in the manufacturing 
or date of entry to the cohort through  process. No information on TCE use, potential TCE exposure 
31 December 1997. Cancer incidence  concentrations, or the percentage of study subjects whose job
ascertained as of 31 December 1997. titles indicated potential TCE exposure.
Chang et al. 2003 Workers employed between 1978 and  86,868 (1,380,355 P-Y) .Mortality 
31 December 1997 at an electronics factory in  rates of Taiwanese population. 
Taiwan. Follow-up began on 1 January 1985 
or date or entry to the cohort through 
31 December 1997. Vital status ascertained 
from 1 January 1985 through 
31 December 1997.
Raaschou-Nielsen  Blue-collar workers employed between 1964  40,049 (14,360 with presumably Employers had documented TCE use. Blue-collar versus 
et al. 2003 and 1997 for at least 3 months and alive as of higher level exposure to TCE)  white-collar workers and companies with ≤ 200 workers were 
1 January 1968 at 347 Danish TCE-using  (339,486 P-Y). Cancer incidence  variables identiﬁed as increasing the likelihood for TCE 
companies. Follow-up for cancer incidence  rates of the Danish population. exposure. Subjects were identiﬁed from the following 
from 1 April 1968 or date of ﬁrst  industries: iron and metal, electronics, painting, printing, 
employment through 31 December 1997. chemical, and dry cleaning.
Abbreviations: JEM, job exposure matrix; P-Y; person-years; U-TCA, urinary trichloroacetic acid.TCE cancer epidemiology
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Table 2. Case–control epidemiologic studies examining cancer and TCE exposure.
Cases Controls Response 
Reference Population (no.) (no.) rate (%) Exposure assessment Statistical analysis
Brain (neuroblastoma)
DeRoos et al.  Cases in children ≤ 19 years of age selected  504 504 Cases, 73  Telephone interview with parent  Logistic regression with 
2001 from Children’s Cancer Group and Pediatric  Controls, 74 using questionnaire to assess  covariate for child’s age and 
Olshan et al.  Oncology Group with diagnosis in 1992–1994; parental occupation and  material race, age, and 
1999 population controls (random digit dialing)  self-reported exposure history and education.
matched to control for birth date. judgment-based attribution of 
exposure to TCE and other solvents.
Rectal
Dumas et al.  Male cases, 35–70 years of age, diagnosed in  257 1,295 Cases, 85 In-person or telephone interview to  Logistic regression analyses 
2000 1979–1985 and histologically conﬁrmed;  (group 1) Controls, 100 assess self-reported occupational  adjusted for age, education, 
controls with cancers at other sites chosen  533  (group 1) history: TCE exposure assigned to  cigarette smoking, beer 
from same cancer registry as cases (group 1)  (group 2) Controls, 72 subject using work history obtained  consumption, body mass 
or population controls (group 2). (group 2) by interview and JEM. index,and respondent status.
Renal cell
Brüning et al.  Histologically conﬁrmed cases from German  134 401 Cases, 83 In-person interview with case or  Logistic regression with 
2003 hospitals (Arnsberg) in 1992–2000; controls  Controls, no  next-of-kin; questionnaire  covariates for age, sex, and 
frequency-matched (one case, three controls)  information assessing occupational history  smoking.
by sex and age to cases, from hospitals with  using job title and JEM of Pannett 
urology department (and local geriatric  et al. (1985).
department for older controls) serving 
Arnsberg.
Charbotel et al.  Histologically conﬁrmed cases from three  86 316 Cases, 74 Blinded telephone interview with  Matched pairs conditional 
2005, 2006 hospitals and urologists in the High Savoy  Controls, 78 case or next-of-kin; questionnaire  logistic regression with 
Fevotte et al. area and surrounding region in France and  assessing occupational history  covariates for body mass 
2006 from Geneva, Switzerland, in 1993–2003;  using JTEM or self-reported  index and tobacco smoking.
controls selected from urologists’ files  exposure to assign TCE and other 
matched 1:4 to case for birth year and sex. exposures.
Pesch et al. Histologically conﬁrmed cases from 935 4,298 Cases, 88 In-person interview with case or  Logistic regression with 
2000a German hospitals (ﬁve regions) in 1991–1995; Controls, 71 next-of-kin; questionnaire assessing  covariates for age, family 
controls randomly selected from residency  occupational history using job title  income, ethnicity, smoking, 
registries matched for region, sex, and age. or self-reported exposure to assign  and respondent status.
TCE and other exposures.
Urothelial
Pesch et al.  Histologically conﬁrmed cases from 1,035 4,298 Cases, 84 In-person interview with case or  Logistic regression with 
2000b German hospitals (ﬁve regions) in 1991–1995; Controls, 71 next-of-kin; questionnaire assessing  covariates for age, family
controls randomly selected from residency  occupational history using job title  income, ethnicity, smoking, 
registries matched for region, sex, and age. or self-reported exposure to assign  and respondent status.
TCE and other exposures. 
JTEM, job-task exposure matrix. 
Table 3. Community studies on cancer and TCE exposure. 
Reference Description Statistical methods Exposure assessment
Ahrens et al. 2001  Incident leukemia cases from 1978–1982 from Illustration  of  three statistical methodologies Residence in census tract or census block group 
Waller and Turnbull 1993 eight counties in upstate New York. to assess clustering of leukemia cases and  with a previously identiﬁed inactive hazardous 
Waller et al. 1992 12 hazardous waste sites.  waste site.
Turnbull et al. 1990
Aickin 2004 Deaths due to cancer, including leukemia,  Standardized rate ratios for mortality from  Resident of Maricopa County, AZ, at the 
Aickin et al. 1992 congenital anomalies, injuries, and cardio- Poisson regression modeling. Childhood  time of diagnosis or death as surrogate for 
Flood et al. 1990, 1997 vascular diseases in 1966–1986 and childhood leukemia incidence data evaluated using exposure. 
Flood and Chapin 1988 leukemia incident cases (1965–1986) among  Bayes methods and Poisson regression 
residents of Maricopa County, Arizona. modeling. 
Costas et al. 2002,  Childhood leukemia (≤ 19 years age)  Logistic regression with composite covariate, Questionnaire administered to parents separately 
Massachusetts  diagnosed in 1969–1989 in residents of a  weighted variable of individual covariates. assessing demographic and lifestyle 
Department of Public Woburn, MA; controls randomly selected  characteristics, medical history information, 
Health 1997 from Woburn public school records,  environmental and occupational exposure, and 
matched for age. use of public drinking water in the home. 
Hydraulic mixing model used to infer drinking 
water containing TCE and other solvents 
delivered to residence.
Lee et al. 2003 Cancer deaths in 1966–1997 in two villages in  Mortality OR using Mantel-Haenszel method  Location of residence as recorded on death 
Taiwan; controls were cardiovascular and  and stratiﬁed by gender and age and  certiﬁcate. Monitoring in 1999–2000 of TCE in 
cerebrovascular disease deaths from same  logistic regression with covariates for age groundwater  or  well water was used to infer 
underlying area as cases. and period. exposure to TCE to village residents.
Morgan and Cassady 2002 Cancer cases diagnosed between 1 April 1988  Standardized incidence rates for all cancer  TCE and perchlorate detected in some county 
and 31 December 1998 among residents of  sites and 16 site-speciﬁc cancers; expected  wells; no information on distribution of 
13 census tracts in Redlands area, San  numbers of cancers using incidence rates  contaminated water to residents. TCE 
Bernardino County, CA. of site-speciﬁc cancer of a four-county  concentrations in water after 1991 were below 
region in 1988–1992. maximum contaminant level of 5 ppb.
OR, odds ratio.case of Raaschou-Nielsen et al. (2003), num-
bers of exposed NHL cases are small, limiting
statistical power. The one available case–con-
trol study observed a strong but imprecise asso-
ciation between maternal exposure to
TCE-contaminated drinking water during
pregnancy and childhood leukemia (Costas
et al. 2002). Aickin (2004) provides further
evidence for an association between TCE in
drinking water and childhood leukemia.
Analyses using Bayesian statistical methods
confirmed an elevated mortality in children
from leukemia. Examining childhood leukemia
incidence, Aickin (2004) reported that a rate
ratio ≤ 1.0 was not credible, and risk > 2.0
could not be ruled out.
To illustrate the potential impact of these
new studies, Figures 1–4 show relative risks,
SIRs, and standardized mortality ratios (SMRs)
from cohort studies and ORs from case–con-
trol studies for four cancer sites discussed above
(liver, liver and biliary passages, kidney, and
NHL, respectively). These ﬁgures include stud-
ies published before 2000 [reviewed in, e.g.,
Wartenberg et al. (2000)] and those discussed
above. The integration of this new information
will contribute substantially to the hazard char-
acterization of a TCE health evaluation and
become an integral part of the U.S. EPA
revised TCE risk assessment. However, this
integration requires consideration of a number
of key issues related to interpretation and syn-
thesis, as discussed below.
Issues Related to TCE
Epidemiologic Evidence
Studies of cancer incidence or cancer mortality.
Both cancer incidence and cancer mortality rates
are potentially useful in risk assessment for iden-
tifying hazards and assessing dose–response rela-
tionships. Incidence rates, generally considered
to provide an accurate indication of risk of a
Scott and Chiu
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Table 4. Select epidemiologic studies: site-speciﬁc cancer and exposure to TCE.
Exposed Estimated  relative
Reference Study population cases (no.) risk (95% CI)
Total cancer
Cohort studies
Hansen et al. 2001 Male 109 1.0 (0.9–1.3)
Female 19 1.0 (0.6–1.6)
Chang et al. 2003 Male 66 0.7 (0.5–0.8)
Female 250 1.0 (0.9–1.1)
Raaschou-Nielsen et al.  Male 2,434 1.1 (1.0–1.1)
2003 Female 624 1.2 (1.1–1.3)
Community studies
Lee et al. 2003 Upstream village 266a 1.0
Downstream village 2.1 (1.3–3.3)b
Morgan and Cassady  13 census tracts in San 
2002 Bernardino County, CA  3,098 1.0 (0.9–1.0)
Bladder
Cohort studies
Hansen et al. 2001 Male 10 1.1 (0.5–2.0)
Female 0
Chang et al. 2003 Male 1 1.0 (0.01–5.4)
Female 1 1.0 (0.01–5.4)
Raaschou-Nielsen et al.  Male 203 1.0 (0.9–1.2)
2003 Female 17 1.6 (0.9–2.6)
Zhao et al. 2005c Low TCE score 7 1.0
Medium TCE score 7 1.5 (0.8–2.9)
High TCE score 3 2.0 (0.9–4.2)
Case–control studies
Pesch et al. 2000b JTEM, male
Medium TCE exposure 47 0.8 (0.6–1.2)
High TCE exposure 74 1.3 (0.9–1.7)
Substantial TCE exposure 36 1.8 (1.2–2.7)
Community studies
Morgan and Cassady  13 census tracts in San 
2002 Bernardino County, CA 82 1.0 (0.8–1.2)
Breast
Cohort studies
Hansen et al. 2001 Female 4 0.9 (0.2–2.3)
Chang et al. 2005 Female 215 1.2 (1.0–1.4)
Raaschou-Nielsen et al.  Male 2 0.5 (0.1–1.9)
2003 Female 145 1.1 (0.9–1.2)
Community studies
Morgan and Cassady  Females in 13 census tracts in  536 1.1 (1.0–1.2)
2002 San Bernardino County, CA
Esophagus
Cohort studies
Hansen et al. 2001 Male 6 4.2 (1.5–9.2)
Female 0
Chang et al. 2005 Male 0
Female 0
Raaschou-Nielsen et al.  Male 23d 1.8 (1.2–2.7)
2003 Female 0
Zhao et al. 2005c,e Low TCE score 7 1.0
Medium TCE score 7 1.7 (0.6–4.4)
High TCE score 3 1.3 (0.2–4.0)
CI, conﬁdence interval. 
aTotal cancer deaths in the two villages. b99% CI. cZhao et al. (2005) present both cancer
incidence and cancer mortality. Relative risks in this table are for cancer incidence.
dAdenocarcinoma of the esophagus. eEsophageal and stomach cancer incidence.
Table 5. Select epidemiologic studies: kidney or renal cell cancer and exposure
to TCE.
Exposed  Estimated relative 
Reference Study population cases (no.) risk (95% CI)
Cohort studies
Hansen et al. 2001 Male 3 0.9 (0.2–2.6)
Female 1 2.4 (0.03–14)
Chang et al. 2005 Male 0
Female 3 1.2 (0.2–3.4)
Raaschou-Nielsen et al. Male 93 1.2 (1.0–1.5)
2003 Female 10 1.2 (0.6–2.1)
Duration of employment, 
male
≤ 1 year 14 0.8 (0.5–1.4)
1–4.9 years 25 1.2 (0.8–1.7)
≥ 5 years 29 1.6 (1.1–2.3)
Duration of employment, 
female
≤ 1 year 2 1.1 (0.1–3.8)
1–4.9 years 3 1.2 (0.2–3.5)
≥ 5 years 3 1.5 (0.3–4.3)
Zhao et al. 2005a Low TCE score 6 1.0
Medium TCE score 6 1.9 (0.6–6.2)
High TCE score 4 4.9 (1.2–20)
Case–control
Pesch et al. 2000a JTEM, male
Medium exposure 68 1.3 (1.0–1.8)
High exposure 59 1.1 (0.8–1.5)
Substantial exposure 22 1.3 (0.8–2.1)
JTEM, female
Medium exposure 11 1.3 (0.7–2.3)
High exposure 7 0.8 (0.4–1.9)
Substantial exposure 5 1.8 (0.6–5.0)
Brüning et al. 2003 Employment in industry  117 1.8 (1.2–2.7)
with TCE exposure
Self-assessed, TCE 25 2.5 (1.4–4.5)
Duration of exposure
No exposure 109 1.0
≤ 10 years 14 3.8 (1.5–9.3)
10– ≤ 20 years 13 1.8 (0.7–4.8)
20+ years 6 2.7 (0.8–8.7)
Charbotel et al. 2005,  Cumulative TCE dose
2006 Nonexposed 49 1.0
Low 12 1.6 (0.8–3.5)
Medium 9 1.2 (0.5–2.8)
High 16 2.2 (1.0–4.6)
Cumulative TCE dose + peaks
Nonexposed 49 1.0
High + peaks 8 2.7 (1.1–7.1)
Community studies
Morgan and Cassady  13 census tracts in  54 0.8 (0.6–1.1)
2002 San Bernardino County, CA
aZhao et al. (2005) present both cancer incidence and cancer mortality. Relative risks in
this table are for cancer incidence.TCE cancer epidemiology
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disease in a population, are rarely available. In
the absence of incidence data, epidemiologic
studies have commonly relied on mortality data
to assess exposure–disease associations. An
understanding of the accuracy of death certiﬁ-
cate information as a surrogate for incidence
data is important for evaluating observations in
the mortality studies. Known inaccuracies exist
between cancer incidence and death certiﬁcate
recordings for some cancer sites important to
evaluating TCE exposure, for example, cancer of
liver (primary) and liver and biliary passages
(Percy et al. 1990). In their study of death cer-
tiﬁcate accuracy, Percy et al. (1990) showed that
only 53% of 2,388 incident cases of primary
liver cancer were actually attributed on the death
certiﬁcate to this disease. Zhao et al. (2005) were
able to examine both incidence and mortality
among TCE-exposed workers and observed
underreporting on death certiﬁcates for several
site-speciﬁc cancers, including NHL, leukemia,
and kidney and bladder cancers.
Death certificate inaccuracies would
obscure exposure–disease associations toward
the null by reducing statistical power and may
explain apparent inconsistencies between epi-
demiologic studies using incidence data versus
those based on death certiﬁcations. For exam-
ple, apparent inconsistencies in some observa-
tions from cohort studies of American workers,
which were primarily based on mortality, and
cohort studies of Nordic workers, which were
largely based on incidence, may reﬂect misclas-
siﬁcation of death certiﬁcates compared with
incidence data.
Non-Hodgkin lymphoma. Lymphoma,
including NHL, is a disease composed of
numerous, etiologically distinct neoplasms
(Fisher 2003; Herrinton 1998). Several issues
may affect interpretation of NHL associations
in the TCE epidemiologic studies and may be
important to evaluating the consistency, or
lack there of, across studies. First, epidemio-
logic studies evaluating NHL and TCE
exposure have used a number of different
International Classification of Diseases (ICD)
revisions. All four Nordic studies (Anttila et al.
1995; Axelson et al. 1994; Hansen et al. 2001;
Raaschou-Nielsen et al. 2003) classiﬁed NHL
according to the seventh revision of the ICD
[ICD-7; World Health Organization (WHO)
1957], and all reported consistent findings.
Other revisions of the ICD were used in the
more recent studies by Blair et al. (1998) [ICD
Adapted (ICDA)-8, National Center for
Health Statistics 1967], Boice et al. (1999)
(ICD-9, WHO 1977), Garabrant et al. (1988)
(ICD-9 in effect at date of death: ICD-7,
ICDA-8, or ICD-9), Morgan et al. (1998,
2000) (ICD in effect at date of death: ICD-7,
ICDA-8, or ICD-9), and Ritz (1999) (ICD-9).
Few case–control studies on lymphoma are
available. NHL cases in Hardell et al. (1994)
were histologically veriﬁed and were classiﬁed
using the Rappaport system. Persson et al.
(1989) do not identify the system used to
classify NHL cases in their study. Classiﬁcation
of lymphomas has changed with each revision.
Second, understanding of histopathologic
and immunologic characteristics of lymphoma
has grown since 1977, the publication date of
ICD-9. Past classiﬁcations of lymphomas do
not reﬂect the current biologic understanding
of NHL and do not make distinctions between
different cell types. From this perspective, lym-
phomas are deﬁned broadly as B-cell and T-cell
lymphomas, with further divisions into precur-
sor neoplasms and mature neoplasms (Cogliatti
and Schmid 2002). This implies that lym-
phomas classiﬁed in the past into distinct cate-
gories may share common biological properties
and differentiation pathways. For example, a
lymphoma of B-cell origin may be classified
under older schemes as NHL, multiple
myeloma, or leukemia. Emerging data on mol-
ecular markers of lymphoma suggest stage of
cell differentiation at time of exposure as an
important factor in NHL development (Staudt
and Dave 2005).
Exposure assessment issues in TCE epidemi-
ologic studies. The methods by which exposure
is assessed in epidemiologic studies of TCE 
are diverse, ranging from use of broad job or
industry categories to analysis of biomonitoring
data. Generally, greater weight is assigned to
studies with more precise and speciﬁc exposure
estimates. Careful evaluation of a study’s expo-
sure assessment method is important in the
evaluation of a body of epidemiologic data, par-
ticularly if divergent observations may be due to
exposure misclassiﬁcation bias reﬂecting incor-
rect assignment of study subjects to exposure
groups. Many of the TCE studies lack actual
exposure measurements for individual subjects,
and surrogates such as available current or his-
torical monitoring data are often used to recon-
struct exposure parameters.
The three Nordic cohorts of Axelson et al.
(1994), Anttila et al. (1995), and Hansen et al.
(2001) identiﬁed study subjects using the TCE
biological marker of urinary trichloroacetic
acid (U-TCA), which provides some evidence
of past TCE exposure, although usually not a
full exposure history. These studies carry
weight in the overall analysis because of their
greater precision of exposure assessment com-
pared with methods discussed below for other
cohorts; however, a consideration of statistical
Table 6. Select epidemiologic studies: liver cancer and exposure to TCE.
Exposed cases Estimated relative risk 
Reference Study population (no.) (95% CI)
Liver, primary
Cohort studiesa
Hansen et al. 2001
Hansen 2004 Male, female 2 1.7 (0.2–6.0)
Chang et al. 2003 Male 0
Female 0
Raaschou-Nielsen et al. 2003 Male 27 1.1 (0.7–1.6)
Female 7 2.8 (1.1–5.8)
Duration of employment, male
≤ 1 year 9 1.3 (0.6–2.5)
1–4.9 years 9 1.0 (0.5–1.9)
≥ 5 years 9 1.1 (0.5–2.1)
Duration of employment, female
≤ 1 year 2 2.8 (0.3–10)
1–4.9 years 4 4.1 (1.1–11)
≥ 5 years 1 1.3 (0.0–7.1)
Liver and bile ducts
Cohort studiesa
Hansen et al. 2001
Hansen 2004 Male and female 5 2.1 (0.7–4.9)
Chang et al. 2003 Not reported
Raaschou-Nielsen et al. 2003 Males 41 1.1 (0.8–1.5)
Females 16 2.8 (1.6–4.5)
Duration of employment, male
≤ 1 year 13 1.2 (0.6–2.1)
1–4.9 years 13 0.9 (0.5–1.6)
≥ 5 years 15 1.1 (0.6–1.7)
Duration of employment, female
≤ 1 year 4 2.5 (0.7–6.4)
1–4.9 years 10 4.5 (2.1–8.3)
≥ 5 years 2 1.1 (0.1–3.8)
Community studies
Lee et al. 2003 Upstream village 53b 1.0
Downstream village 2.6 (1.2–5.5)
Morgan and Cassady 2002 13 census tracts in  28 1.3 (0.9–1.9)
San Bernardino County, CA
aZhao et al. (2005) did not present relative risks for liver or liver and bile duct cancer in their article. bTotal liver cancer
deaths in the two villages.Scott and Chiu
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power is also important because of fewer sub-
jects compared with cohorts identified using
other methods.
Other cohort and case–control studies have
adopted a number of approaches for exposure
assessment. TCE exposure has been assigned to
subjects using surrogate information based on
patterns of TCE use by job title obtained from
historical job descriptions, from historical indus-
trial hygiene surveys, or from personal interviews
to develop job exposure matrices (JEMs). For
several cohorts, industrial hygiene measurements
either were absent before the 1970s (Boice et al.
1999; Marano et al. 2000; Morgan et al. 1998,
2000) or were quite limited (Blair et al. 1998;
Stewart et al. 1991). Furthermore, some cohort
(Ritz 1999) and case–control (Greenland et al.
1994) studies classiﬁed study subjects as TCE
exposed using information obtained from per-
sonal interviews or generic JEMs or job-task
exposure matrices (JTEMs) in the absence of
historical monitoring. Two issues associated
with the use of generic JEMs are sensitivity (i.e.,
the ability to identify study subjects as exposed)
and speciﬁcity (i.e., the ability to identify study
subjects as not exposed).
Still other cohort studies (Chang et al.
2003, 2005; Costa et al. 1989; Garabrant et al.
1988) have deﬁned exposure using occupation
and industry. TCE is identified as one of a
number of potential exposures, but no infor-
mation is provided on individual subjects with
TCE exposure. The main shortcoming of this
type of study is that the lack of an association
with a particular job or industry may mask the
effect of exposure to a specific chemical to
which only some individuals in the job are
exposed (Teschke et al. 2002). For this reason,
a consideration of potential exposure misclassi-
fication bias is important in weighting these
studies in an overall weight of evidence.
In addition, multiple solvents and chemical
agents are common in the TCE studies, adding
to the complexity of exposure assessment and
inferences about causality. Some studies of
TCE also identify exposures to other chlori-
nated solvents such as perchloroethylene and
1,1,1-trichloroethane (Blair et al. 1998; Boice
et al. 1999; Marano et al. 2000; Morgan et al.
1998, 2000; Stewart et al. 1991; Zhao et al.
2005). The potential for exposure to multiple
chlorinated solvents is an important considera-
tion in the TCE epidemiologic studies for two
reasons. First, these chemicals can share similar
metabolic proﬁles or modes of action as TCE
(U.S. EPA 2001), and second, some epidemio-
logic studies have also reported independent
associations between exposure to these other
Table 7. Select epidemiologic studies: lymphoma and exposure to TCE.
Exposed cases Estimated relative risk
Reference Study population (no.) (95% CI)
NHL
Cohort studies
Hansen et al. 2001 Male 8 3.5 (1.5–6.9)
Female 0
Duration of employment, male
Unknown 2 3.7 (0.4–13)
≤ 6.25 years 2 2.5 (0.3–9.2)
≥ 6.25 years 4 4.2 (1.1–11)
Chang et al. 2005 Male 5 1.3 (0.4–3.0)
Female 10 1.1 (0.6–2.1)
Raaschou-Nielsen et al. 2003 Male 83 1.2 (1.0–1.5)
Female 13 1.4 (0.7–2.3)
Duration of employment, male
≤ 1 year 23 1.1 (0.7–1.6)
1–4.9 years 33 1.3 (0.9–1.8)
≥ 5 years 27 1.4 (0.9–2.0)
Duration of employment, female
≤ 1 year 2 0.7 (0.1–2.4)
1–4.9 years 6 1.6 (0.6–3.5)
≥ 5 years 5 1.8 (0.6–4.3)
Zhao et al. 2005a Low TCE score 28 1.0
Medium TCE score 16 0.9 (0.5–1.7)
High TCE score 1 0.2 (0.03–1.5)
Community studies




Hansen et al. 2001 Male 5 1.9 (0.6–4.4)
Female 1 3.1 (0.04–18)
Chang et al. 2005 Male 2 0.4 (0.05–1.6)
Female 8 0.5 (0.2–1.1)
Raaschou-Nielsen et al. 2003 Male 69 1.1 (0.8–1.4)
Female 13 1.7 (0.9–2.9)
Community studies
Costas et al. 2002 Exposed to water from TCE-
contaminated wells G and H
2 years before pregnancy to 
leukemia diagnosis
Never 3 1.0
Least 9 5.0 (0.7–34)
Most 7 3.6 (0.5–25)
Exposed to water from TCE-
contaminated wells G and H
during pregnancy
Never 9 1.0
Least 3 3.5 (0.2–58)
Most 7 14 (0.9–224)b
Morgan and Cassady 2002 13 census tracts in San  77 1.0 (0.8–1.3)
Bernardino County, CA
aZhao et al. (2005) present both cancer incidence and cancer mortality. Relative risks in this table are for NHL and
leukemia incidence combined. bTest for trend is statistically signiﬁcant, p ≤ 0.05.
Figure 1. Relative risks (SIRs or SMRs) for primary
liver cancer in occupational cohort studies of TCE-
exposed workers. Abbreviations: F, female; M,
male. No case–control studies of primary liver can-




Anttila et al. (1995)
Blair et al. (1998)
Hansen et al. (2001)
Raaschou-Nielsen et al. (2003) (M)
Raaschou-Nielsen  et al. (2003) (F)
Figure 2. Relative risks for liver and biliary passage
cancer in occupational cohort studies on TCE. SIRs
or SMRs are presented for occupational cohort
studies, and ORs for the case–control study. 
Garabrant et al. (1988)
Costa et al. (1989)
Axelson et al. (1994)
Anttila et al. (1995)
Blair et al. (1998)
Morgan et al. (1998)
Boice et al. (1999)
Ritz et al. (1999)
Hansen et al. (2001)
Raaschou-Nielsen et al. (2004) (M)
Raaschou-Nielsen  et al. (2004) (F)





Case–control studysolvents and cancer (Blair et al. 1998; Zhao
et al. 2005). Physiologically based pharmacoki-
netic models such as those discussed by Chiu
et al. (2006b) may be useful for better under-




The practice of causal inference in environmen-
tal epidemiology relies on three approaches:
narrative reviews, criteria-based inference
methods, and, increasingly, meta-analysis
(Weed 2002). All three have been employed in
various analyses of the epidemiologic literature
on cancer and TCE exposure. Narrative
reviews of a body of epidemiologic evidence
generally do not fully consider potential biases
and confounding factors. By contrast, criteria-
based approaches for assessing causality evalu-
ate evidence according to a set of criteria or
standards applied to the evidence (Weed
2002). For instance, the aspects proposed by
Sir Bradford Hill (1965) are widely cited for
framing the factors to consider in determining
whether statistical associations are likely to be
causal. Similar criteria are also presented in the
U.S. EPA Guidelines for Carcinogen Risk
Assessment (U.S. EPA 2005).
Criteria-based approaches have increasingly
been supplemented with formal statistical
methods such as meta-analysis for reviewing
and summing a body of evidence (Weed 2002).
Common meta-analytic methods can include
ﬁtting of ﬁxed-effects or random-effects models,
linear regression analysis to assess dose–
response, or pooled analyses. Pooled analysis of
the Nordic studies may be more feasible
because of their similar design and similar
follow-up period for documenting cancer inci-
dence than for other TCE cohorts. As discussed
in the overview article of this mini-monograph
by Chiu et al. (2006a), the NAS has been asked
to provide advice on appropriate meta-analysis
methods, including the classification and
weighting of individual studies.
Discussion and Summary
The U.S. EPA draft TCE assessment (U.S.
EPA 2001) noted that epidemiologic studies,
when considered as a whole, have associated
TCE exposure with excess risk of kidney, liver,
lymphohematopoietic, cervical, and prostate
cancer. Recently published studies appear to
provide further support for several of those
conclusions, suggesting, as do previous studies,
modestly elevated site-specific risk (typically
between 1.5 and 2.0), given exposure condi-
tions in the epidemiologic studies.
The recent epidemiologic studies strengthen
the evidence that the kidney is a target of TCE
toxicity. It should be noted that kidney toxicity
besides cancer has been found by Radican et al.
(2006), who reported a statistically signiﬁcant
association with end-stage renal disease mortal-
ity and exposure to solvents, including TCE.
Understanding the mechanism by which TCE
may act in kidney toxicity, including cancer, can
inform cause–effect evaluations. The glu-
tathione S-transferase (GST) metabolic pathway
has been hypothesized as important to mode-of-
action considerations (Caldwell and Keshava
2006), and GST polymorphisms are reported to
inﬂuence RCC risk associated with TCE expo-
sure (Brüning et al. 1997). Brauch et al. (2004)
examined somatic mutation to the von Hippel-
Lindau tumor suppressor gene in renal cell
tumors of non-TCE-exposed cases, comparing
the prevalence of mutation to that found in
renal tumors of TCE-exposed subjects reported
in an earlier publication (Brauch et al. 1999). A
higher prevalence of somatic mutations was
found in renal cell tumors of TCE-exposed cases
than in tumors of non-TCE-exposed cases.
Moreover, the C > T transition at nucleotide
454, detected in some RCCs from TCE-
exposed subjects, was not found among the
non-TCE-exposed RCC cases.
The recent studies also support the liver
and immune system as being targets for TCE
toxicity, with most of these studies showing ele-
vated (and in some cases statistically signiﬁcant)
cancer risks from TCE exposure. However,
although the number of studies assessing pri-
mary liver cancer separately from biliary tract
cancers has doubled, the total number is still
only 4, compared to 11 examining the com-
bined category. With lymphomas, there are also
a number of classiﬁcation issues, including the
use of different ICD revisions, and the fact that
these groupings may lump together etiologically
distinct neoplasms. Moreover, studies evaluat-
ing these end points include both incidence and
mortality studies, which may have different sen-
sitivity and biases. Thus, the reduced speciﬁcity
in most studies, in combination with the rela-
tively small number of total cases due to low
background incidence, complicates interpreta-
tion of these ﬁndings.
Of particular importance for assessment of
epidemiologic evidence on TCE exposure is
characterizing the totality of the evidence in
light of factors that may contribute to false posi-
tive ﬁndings or to false negative observations.
The evidence presented on issues regarding data
sources, exposure assessment, and disease classi-
ﬁcation can inﬂuence the statistical power of
the epidemiologic study to detect whether there
is an underlying risk. The challenge is to con-
sider these issues, along with well-articulated
approaches when evaluating the body of evi-
dence, including the application of meta-analy-
sis methods and rationale for grouping
individual studies, in identifying hazards and
drawing causal conclusions.
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